Description
Over time, tumor treatment resistance inadvertently develops when androgen de-privation therapy (ADT) is applied to metastasized prostate cancer (PCa). To combat tumor resistance, while reducing the harsh side effects of hormone therapy, the clinician may opt to cyclically alternates the patient’s treatment on and off.
Copyright Statement
Download count: 0
Details
Contributors
- Bennett, Justin Klark (Author)
- Kuang, Yang (Thesis director)
- Kostelich, Eric (Committee member)
- Phan, Tin (Committee member)
- School of Mathematical and Statistical Sciences (Contributor, Contributor)
- Barrett, The Honors College (Contributor)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2021-05
Subjects
Resource Type
Collections this item is in